דילוג לתוכן הראשי
xMedica

NCT07746531ClinicalTrials.gov

Robotic Minimally Invasive Benign Hysterectomy Post-Market Clinical Study With the DEXTER Robotic System

מגייסמקבל משתתפים כעת, לפי רשומת המרשם.
יצירת קשר עם המחקר

בקצרה

The purpose of this post-market, observational study is to collect real-world data under anticipated conditions of use that demonstrates that the device performs as intended (accurate, precise control of surgical instruments) in patients undergoing robotic-assisted and laparoscopic hysterectomy for benign…

תצפיתידרושים 112 משתתפים2 אתריםמדינה אחת

רשום במרשם אחד

מחקר יחיד יכול להיות רשום בכמה מרשמים. אנו מציגים אותו פעם אחת ומקשרים לכל רשומה שברשותנו.

מידע הניסוי מוצג כפי שפורסם על ידי המרשם, בשפת המקור שלו.

מתעניינים במחקר הזה?

התחברות או צרו חשבון כדי לרשום את התעניינותכם ולעקוב אחר המחקר הזה.

How this study is set up

The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.

  • Present: Registered before enrolment beganFirst posted 2026-08-05; recorded start 2026-08-20
  • Present: Has a defined primary outcomeA primary outcome measure is listed in the record
  • Present: The primary outcome states a time frameThe primary outcome measure records a time frame
  • Not stated: Whether participants are randomly assigned is not stated in the registry recordNo allocation method is recorded
  • Not stated: Whether there is a comparison group is not stated in the registry recordThe record does not describe the study arms
  • Not stated: Whether the study is blinded is not stated in the registry recordNo masking information is recorded
  • Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
  • Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
  • Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
  • Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
  • Present: Sponsor has 5 other studies in this databaseCounted from the lead sponsor named in the record (Distalmotion SA)
  • Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
  • The record lists 1 condition.
  • Lead sponsor type recorded as: industry.

Trial stature

Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.

Methodological rigourEXPLORATORY

An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.

How this score is built
  • Randomised allocation0/20

    Allocation not stated in the record

  • Blinding0/20

    Masking not stated in the record

  • Control arm0/15

    No comparator arm stated in the record

  • Primary-outcome specificity10/10

    Named primary outcome with a defined time frame

  • Endpoint type3/10

    Surrogate or intermediate endpoint (conservative default)

  • Multi-centre5/8

    Multi-centre: 2 sites

  • Data monitoring committee0/7

    No data monitoring committee stated

  • Prospective registration5/5

    Registered before the study start date

  • Protocol / SAP posted0/5

    No protocol or SAP posted to the registry

ScaleSMALL

A small study: 112 participants (target), run at 2 sites.

How this score is built
  • Enrolment19/40

    112 participants (target)

  • Site count4/25

    2 sites

  • Country count0/15

    Single country

  • Planned duration7/10

    Planned over about 28 months

  • Sponsor scale2/10

    Distalmotion SA has led 6 trials in our corpus

Investigator standingUNKNOWN

We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.

How this score is built
  • Investigator standing0/100

    No investigator recorded in the registry for this trial

These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.

תקציר

The purpose of this post-market, observational study is to collect real-world data under anticipated conditions of use that demonstrates that the device performs as intended (accurate, precise control of surgical instruments) in patients undergoing robotic-assisted and laparoscopic hysterectomy for benign disease.

מצבים רפואיים

  • Hysterectomy, Benign Uterine Diseases

זכאות

זכאות
מיןנקבה
גילאים22 Years – ללא מקסימום
מתנדבים בריאיםלא
שיטת דגימהNON_PROBABILITY_SAMPLE

אוכלוסיית המחקר

Adult patients undergoing a hysterectomy for benign disease

זכאות כפי שנכתבה במרשם

Inclusion Criteria: * Patient is ≥ 22 years of age at time of enrollment/consent * Patient is planned to undergo robotic-assisted and laparoscopic hysterectomy for benign disease * Patient agrees to perform the 6-week follow-up assessment as per standard of care Exclusion Criteria: * Any planned concomitant procedures (not including salpingectomy and/or oophorectomy) * Diagnosed malignant disease on reproductive organs * Uterus myomatous with fibroid \> 10cm

זכאות במשפטים פשוטים

הקריטריונים של רשומה זו טרם פורקו למשפטים נפרדים. טקסט המרשם שלמעלה שלם והוא הגרסה המחייבת.

תכנון המחקר

תכנון המחקר
סוג המחקרתצפיתי
שלבלא צוין ברשומת המרשם
הקצאהלא צוין ברשומת המרשם
מודל ההתערבותלא צוין ברשומת המרשם
מטרה ראשיתלא צוין ברשומת המרשם
הסתרהלא צוין ברשומת המרשם
גיוסדרושים 112 משתתפים

נותן חסות ושותפים

  • Distalmotion SA נותן חסות

התערבויות

  • התקן benign hysterectomy

    Robotic-assisted and laparoscopic hysterectomy for benign disease with the DEXTER robotic surgery system.

מדדי תוצאה

  1. מדד תוצאה ראשוני

    Primary safety outcome

    Occurrence of Clavien-Dindo grades III-V adverse events

    מסגרת זמן up to 42 days after surgery

  2. מדד תוצאה ראשוני

    Primary efficacy outcome

    Successful completion of the DEXTER-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approach

    מסגרת זמן Intraoperative

תאריכים

תאריכים
תאריך התחלה20 באוגוסט 2026 (בפועל)
סיום ראשוני1 בדצמבר 2028 (משוער)
סיום1 בדצמבר 2028 (משוער)
פורסם לראשונה5 באוגוסט 2026 (בפועל)
עודכן לאחרונה17 בנובמבר 2026
התוצאות פורסמולא צוין ברשומת המרשם
המצב אומת לאחרונהנובמבר 2026

בפועל פירושו שהאירוע התרחש. משוער פירושו שנותן החסות צופה אותו. שתי המשמעויות שונות זו מזו.

מיקומים

אתר אחד מגייס

United States

United States
מתקןעירמדינה או אזורמצב
Memorial Hermann-Texas Medical Center - UT Health HoustonHoustonTexasטרם מגייס
Cypress surgery centerWichitaKansasמגייס

מסמכי המחקר

לא צורפו מסמכים ברשומת מרשם זו.

שינויים לאורך זמן

  1. 17 בנובמבר 2026

    המצב השתנה

    Status changed from Not yet recruiting to Recruiting

    NOT_YET_RECRUITINGRECRUITING

  2. 17 בנובמבר 2026

    הגיוס נפתח

    Recruitment opened

    NOT_YET_RECRUITINGRECRUITING